Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mizuyo Nakamura"'
Autor:
Masashi Matsushita, Yusuke Mori, Kyosuke Uchiumi, Takehiro Ogata, Mizuyo Nakamura, Hiroyuki Yoda, Hiroaki Soda, Nobuhiro Takiguchi, Yoshihiro Nabeya, Osamu Shimozato, Toshinori Ozaki
Publikováno v:
FEBS Open Bio, Vol 9, Iss 5, Pp 935-946 (2019)
Receptor‐type protein tyrosine phosphatase κ (PTPRK) is considered to be a candidate tumor suppressor. PTPRK dephosphorylates CD133, which is a stem cell marker; phosphorylated CD133 accelerates xenograft tumor growth of colon cancer cells through
Externí odkaz:
https://doaj.org/article/5dce7d4e79ee46b2909bba714dbb1660
Publikováno v:
Biomolecules, Vol 5, Iss 4, Pp 2854-2876 (2015)
During the lifespan of cells, their genomic DNA is continuously exposed to theendogenous and exogenous DNA insults. Thus, the appropriate cellular response to DNAdamage plays a pivotal role in maintaining genomic integrity and also acts as a molecula
Externí odkaz:
https://doaj.org/article/fa2d2b66123747bcacaeaddcf6045521
Autor:
Takehiro Ogata, Mizuyo Nakamura, Meijie Sang, Hiroyuki Yoda, Kiriko Hiraoka, Danjing Yin, Mexiang Sang, Osamu Shimozato, Toshinori Ozaki
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0179884 (2017)
Suberoylanilide hydroxamic acid (SAHA) represents one of the new class of anti-cancer drugs. However, multiple lines of clinical evidence indicate that SAHA might be sometimes ineffective on certain solid tumors including pancreatic cancer. In this s
Externí odkaz:
https://doaj.org/article/baa09445473d44f690347ae8215e726f
Autor:
Mizuyo Nakamura, Nobuhiro Takiguchi, Hiroyuki Yoda, Osamu Shimozato, Masashi Matsushita, Toshinori Ozaki, Kyosuke Uchiumi, Yusuke Mori, Hiroaki Soda, Takehiro Ogata, Yoshihiro Nabeya
Publikováno v:
FEBS Open Bio
Receptor-type protein tyrosine phosphatase κ (PTPRK) is considered to be a candidate tumor suppressor. PTPRK dephosphorylates CD133, which is a stem cell marker; phosphorylated CD133 accelerates xenograft tumor growth of colon cancer cells through t
Autor:
Kiriko Hiraoka, Meijie Sang, Osamu Shimozato, Takehiro Ogata, Mizuyo Nakamura, Hiroyuki Yoda, Meixiang Sang, Toshinori Ozaki
Publikováno v:
Oncotarget
// Toshinori Ozaki 1 , Mizuyo Nakamura 1 , Takehiro Ogata 1 , Meijie Sang 1, 2 , Hiroyuki Yoda 3 , Kiriko Hiraoka 3 , Meixiang Sang 1, 4 , Osamu Shimozato 1 1 Laboratory of DNA Damage Signaling, Chiba Cancer Center Research Institute, Chiba, Japan 2
Publikováno v:
Current Human Cell Research and Applications ISBN: 9789811072956
Solid tumor tissues often have functional and phenotypical heterogeneities, arising at least in part from the local hypoxic tumor microenvironment (generally O2 concentration is less than 2%). The elevated level of hypoxia is tightly associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::463e7bd996092fdb84488f16df1ec4a6
https://doi.org/10.1007/978-981-10-7296-3_5
https://doi.org/10.1007/978-981-10-7296-3_5
Publikováno v:
Biomolecules, Vol 5, Iss 4, Pp 2854-2876 (2015)
Biomolecules
Biomolecules
During the lifespan of cells, their genomic DNA is continuously exposed to the endogenous and exogenous DNA insults. Thus, the appropriate cellular response to DNA damage plays a pivotal role in maintaining genomic integrity and also acts as a molecu
Autor:
Mizuyo Nakamura, Hiroki Nagase, Kyoko Fujiwara, Kiriko Hiraoka, Toshinori Ozaki, Hirokazu Sugimoto, Meixiang Sang, Hiroyuki Yoda
Publikováno v:
The Febs Journal
Although runt-related transcription factor 2 (RUNX2) is known to be an essential key transcription factor for osteoblast differentiation and bone formation, RUNX2 also plays a pivotal role in the regulation of p53-dependent DNA damage response. In th
Autor:
Mexiang Sang, Osamu Shimozato, Hiroyuki Yoda, Meijie Sang, Toshinori Ozaki, Danjing Yin, Kiriko Hiraoka, Mizuyo Nakamura, Takehiro Ogata
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 7, p e0179884 (2017)
PLoS ONE, Vol 12, Iss 7, p e0179884 (2017)
Suberoylanilide hydroxamic acid (SAHA) represents one of the new class of anti-cancer drugs. However, multiple lines of clinical evidence indicate that SAHA might be sometimes ineffective on certain solid tumors including pancreatic cancer. In this s